Q4 Comp plan

Quote






The question is how many people are going to coast in Q4 while looking for a new job? Only people in the top five have a shot at making the 150 prescriptions to reach the target bonus of $7500.00. Look at your paystub. Did you come close to making the targeted (uncapped bonus) $30k you were told about when you were hired? Does it look more like $20k? The breakdown would be $7500. from Q4 MBOs, $7500. (maybe) from Q1 MBOs which is $15k. While not on MBOs, did you make another $15k grand? Or was it two nickels in Q2 and three quarters in Q3? Everyone needs to take a serious look at their paystubs. Decide whether or not that nice base pay is worth staying for a decrease in bonus every quarter along with increasing crap every quarter. Don't forget that T.N. only wants to pay on new prescriptions in Q1. How are you going to make any money with only new prescriptions?
 


















anonymous said:
I could not have said it better. This is a startup and we are still not making money.

Rayaldee is a good product and will sell. We just need to get out and sell. The money will follow.
Click to expand...
Well who told the street Rayaldee was going to do $70 million this year when we’ll be lucky to hit $10 million? The same people who are taking salaries and bonuses in the seven figure range. Yet, no money is available to adequately contract, instead relying on 501c3’s to shoulder the burden of tier 3 copays. And on the earnings call the same over compensated individuals lay the blame on the sales force. This is going to get real ugly real soon when the expanded sales force fails to approach the $8-$10 million a quarter needed to break even.
 






anonymous said:
The question is how many people are going to coast in Q4 while looking for a new job? Only people in the top five have a shot at making the 150 prescriptions to reach the target bonus of $7500.00. Look at your paystub. Did you come close to making the targeted (uncapped bonus) $30k you were told about when you were hired? Does it look more like $20k? The breakdown would be $7500. from Q4 MBOs, $7500. (maybe) from Q1 MBOs which is $15k. While not on MBOs, did you make another $15k grand? Or was it two nickels in Q2 and three quarters in Q3? Everyone needs to take a serious look at their paystubs. Decide whether or not that nice base pay is worth staying for a decrease in bonus every quarter along with increasing crap every quarter. Don't forget that T.N. only wants to pay on new prescriptions in Q1. How are you going to make any money with only new prescriptions?
Click to expand...

There isn't any Foundation money. Scripts will see a downturn and the "bottle count" is going to come to a screeching halt. Patients can't afford the $200. deductible for Vita. D. They need the money for their hypertension and diabetes.

Coast until you can find something else. I am sick about how little bonus we are making doing this difficult job without reimbursement.
 






anonymous said:
Ok Harvey and Tom here you go, please consider using what is composed here to sell Dr Phil that your going to get what you pay for therefore paying the RSS for refills is important and not to be fucked with:

Constant education to providers related to SHPT disease state as an important chronic condition that should be aggressively managed. Many drs don't understand the disease state as being serious therefore may only manage 25D and not PTH or vice versa, many not look at the CA or Po4 till late stage 4 or early stage 5. They agree to try Rayaldee but are floored by the high cost ($928 per month) but we have to sell them to keep the pt. on Rayaldee and your not going to pay us for that? You are a moron that you think after they put a pt. on something that the refill comes automatically without any hang ups, this is where we really earn our paycheck, dumbass.

Review KDIGO guidelines that recommend analogs and calcitriol not be routinely used to treat SHPT, key word is not but the alternative is very expensive therefore opening the door to alternate RX from calcitriol to Rayaldee and vice versa just to help keep the out of pocket costs down.

Sell Dr that by keeping pts. on Rayaldee with that $155 per month co pay by UHC/AARP will be worth it.

Sell Drs that keeping pts. who have Silver Script insurance who pay 25-33% co insurance is really worth it.

Encourage 501c3 grant monies to help defer the high co-pay cost when those monies are very hard to come by and caregivers hammer us that those funds should be spent on blood pressure, insulin or food and clothing not on a $928 per month V-D analog. 501c3 funds are available if you qualify financially remember?

Sell Dr that treating SHPT is important and should include evaluating 25D, PTH, CA and P04 and that even though you may not get reimbursed for that earlier follow up office visit you should evaluate pts. recently placed on Rayaldee as early as 3 months.

If you not happy with the 30mcg QDHS after 3 months then you have the option to titrate to 60mcgQDHS therefore doubling the co-pay to $310 per month for UHC/AARP or 25-33% for your Silver Script Medicare pts.

Usually chronic conditions prescriptions are written for 12 months, how are you certain the Dr. will keep the pt. on Rayaldee for another 12 months? If we are not going to be paid for those RX then we won't ask for the refill.

Here's the best part, Rayaldee's refill rate is less than 50% after 3 months. In some territories it's less than 30% after 3 months, no pay for refill then no chance the 50% becomes 60% or 30% becomes 50% if we are not following up on existing cases.

God help us all when the newbies who can't even pronounce calcitriol are going to be calling on offices in a few weeks, their job will be to keep your existing pts. on Rayaldee and ask for new business, your bonus depends on it.

This is the most fucked up company I have ever worked for that management would even ponder not paying reps. on TRX, are you stupid or something?
Click to expand...


Yes.
 






anonymous said:
There isn't any Foundation money. Scripts will see a downturn and the "bottle count" is going to come to a screeching halt. Patients can't afford the $200. deductible for Vita. D. They need the money for their hypertension and diabetes.

Coast until you can find something else. I am sick about how little bonus we are making doing this difficult job without reimbursement.
Click to expand...

Interesting how the company ran out of samples right after the Foundations ran out of money. Is it bad timing or a devious plan to lower the Q4 bonus potential? How many patients are we going to lose due to no Foundation money, lack of reimbursement and no samples? MB stated on the PAP conference call that the Foundations may not receive an infusion of money until late Jan.
 






anonymous said:
Interesting how the company ran out of samples right after the Foundations ran out of money. Is it bad timing or a devious plan to lower the Q4 bonus potential? How many patients are we going to lose due to no Foundation money, lack of reimbursement and no samples? MB stated on the PAP conference call that the Foundations may not receive an infusion of money until late Jan.
Click to expand...
No samples too?
 






anonymous said:
Interesting how the company ran out of samples right after the Foundations ran out of money. Is it bad timing or a devious plan to lower the Q4 bonus potential? How many patients are we going to lose due to no Foundation money, lack of reimbursement and no samples? MB stated on the PAP conference call that the Foundations may not receive an infusion of money until late Jan.
Click to expand...

No samples were sent out last week.
 












Top Bottom
Back
Quote